These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 15455372
1. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Hussain T, Gupta S, Adhami VM, Mukhtar H. Int J Cancer; 2005 Feb 10; 113(4):660-9. PubMed ID: 15455372 [Abstract] [Full Text] [Related]
2. Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats. Li ZG, Shimada Y, Sato F, Maeda M, Itami A, Kaganoi J, Komoto I, Kawabe A, Imamura M. Int J Oncol; 2002 Dec 10; 21(6):1275-83. PubMed ID: 12429978 [Abstract] [Full Text] [Related]
3. Cyclooxygenase-2 promotes prostate cancer progression. Fujita H, Koshida K, Keller ET, Takahashi Y, Yoshimito T, Namiki M, Mizokami A. Prostate; 2002 Nov 01; 53(3):232-40. PubMed ID: 12386924 [Abstract] [Full Text] [Related]
8. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. Brusselmans K, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV. Int J Cancer; 2003 Oct 10; 106(6):856-62. PubMed ID: 12918062 [Abstract] [Full Text] [Related]
9. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Subbarayan V, Sabichi AL, Llansa N, Lippman SM, Menter DG. Cancer Res; 2001 Mar 15; 61(6):2720-6. PubMed ID: 11289153 [Abstract] [Full Text] [Related]
14. Phospholipase D isozymes mediate epigallocatechin gallate-induced cyclooxygenase-2 expression in astrocyte cells. Kim SY, Ahn BH, Min KJ, Lee YH, Joe EH, Min DS. J Biol Chem; 2004 Sep 10; 279(37):38125-33. PubMed ID: 15210717 [Abstract] [Full Text] [Related]
17. Novel antineoplastic isochalcones inhibit the expression of cyclooxygenase 1,2 and EGF in human prostate cancer cell line LNCaP. Johnson KP, Rowe GC, Jackson BA, D'Agustino JL, Campbell PE, Guillory BO, Williams MV, Matthews QL, McKay J, Charles GM, Verret CR, Deleon M, Johnson DE, Cooke DB. Cell Mol Biol (Noisy-le-grand); 2001 Sep 10; 47(6):1039-45. PubMed ID: 11785654 [Abstract] [Full Text] [Related]
18. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Stuart EC, Scandlyn MJ, Rosengren RJ. Life Sci; 2006 Nov 17; 79(25):2329-36. PubMed ID: 16945390 [Abstract] [Full Text] [Related]
19. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M, Mukhtar H. Clin Cancer Res; 2007 Mar 01; 13(5):1611-9. PubMed ID: 17332308 [Abstract] [Full Text] [Related]
20. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Lee SC, Chan WK, Lee TW, Lam WH, Wang X, Chan TH, Wong YC. Nutr Cancer; 2008 Mar 01; 60(4):483-91. PubMed ID: 18584482 [Abstract] [Full Text] [Related] Page: [Next] [New Search]